West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

$143.09
-0.24 (-0.17 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
$142.25
Now: $143.09
$144.00
50-Day Range
$134.91
MA: $143.69
$151.17
52-Week Range
$91.75
Now: $143.09
$152.10
Volume726,428 shs
Average Volume361,962 shs
Market Capitalization$10.55 billion
P/E Ratio50.92
Dividend Yield0.42%
Beta1.27
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. Read More…

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 billion
Cash Flow$4.2624 per share
Book Value$18.85 per share

Profitability

Net Income$206.90 million

Miscellaneous

Employees7,700
Market Cap$10.55 billion
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services declared a quarterly dividend on Thursday, July 25th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

How will West Pharmaceutical Services' stock buyback program work?

West Pharmaceutical Services announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 15th 2018, which allows the company to buyback 800,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's board believes its shares are undervalued.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) issued its quarterly earnings results on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.17. The medical instruments supplier had revenue of $469.70 million for the quarter, compared to analyst estimates of $459.90 million. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.70 EPS. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.89. The company issued revenue guidance of $1.810-1.825 billion, compared to the consensus revenue estimate of $1.81 billion.

What price target have analysts set for WST?

3 brokers have issued 12-month price targets for West Pharmaceutical Services' stock. Their forecasts range from $112.16 to $122.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $117.08 in the next year. This suggests that the stock has a possible downside of 18.2%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

News stories about WST stock have trended negative on Friday, according to InfoTrie. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. West Pharmaceutical Services earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for West Pharmaceutical Services.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a increase in short interest in the month of August. As of August 15th, there was short interest totalling 600,600 shares, an increase of 24.6% from the July 15th total of 481,900 shares. Based on an average daily trading volume, of 292,900 shares, the short-interest ratio is currently 2.1 days. Currently, 0.8% of the shares of the stock are sold short. View West Pharmaceutical Services' Current Options Chain.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Nike (NKE), NVIDIA (NVDA), Medtronic (MDT), Square (SQ), Stanley Black & Decker (SWK), Veeva Systems (VEEV), CVS Health (CVS), Honeywell International (HON), Johnson & Johnson (JNJ) and Walmart (WMT).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (12.07%), Vanguard Group Inc. (9.93%), BlackRock Inc. (9.78%), BlackRock Inc. (9.78%), Bamco Inc. NY (2.16%) and JPMorgan Chase & Co. (2.10%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which major investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Ellis Investment Partners LLC, Renaissance Technologies LLC, First Trust Advisors LP, Schroder Investment Management Group, Janus Henderson Group PLC, Janus Henderson Group PLC, Royal Bank of Canada and Eagle Asset Management Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

Which major investors are buying West Pharmaceutical Services stock?

WST stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., WCM Investment Management LLC, AMI Asset Management Corp, Price T Rowe Associates Inc. MD, Amundi Pioneer Asset Management Inc., AQR Capital Management LLC and BlackRock Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $143.09.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $10.55 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  324 (Vote Underperform)
Total Votes:  529
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2019 by MarketBeat.com Staff

Featured Article: Dividend Achievers

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel